Lataa...
Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species
The selective norepinephrine (NE) α2A-adrenoceptor (α2A-AR) agonist, guanfacine (Intuniv™), is FDA-approved for treating Attention Deficit Hyperactivity Disorder (ADHD) based on research in animals, a translational success story. Guanfacine is also widely used off-label in additional mental disorder...
Tallennettuna:
| Julkaisussa: | Neurobiol Learn Mem |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Author(s). Published by Elsevier Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7567669/ https://ncbi.nlm.nih.gov/pubmed/33075480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nlm.2020.107327 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|